Session
PDF Downloads
Day 1
- What are imaging biomarkers and how can they be used for precision oncology?
- Challenges and opportunities for using real-world data to develop deep-learning imaging biomarkers
- Challenges and best practices for machine learning development at scale for software as a medical device
- Examples of Onc.AI imaging biomarkers to predict immunotherapy response and survival in advanced non-small cell lung cancer throughout the treatment journey
- The presentation compares traditional and generative AI and their implications to the pharma industry, with a focus on commercial insights & analytics and the reporting of such insights. To do so, the presentation will have the following sections:
- The Journey: Different types of AI and pharma examples
- Technology Stack: Can we re-use previous technological investments in AI?
- Use Cases: A commercial data integration, insights, and reporting case study with both discriminative and generative AI
- Risks and challenges: New technology, new biases
- Incorporating AI in organization: Excitement, fatigue, suspicion shapes the new AI landscape in pharma
Kaiwen Zhong - Associate Director, Strategic Data Products - Novartis
Augmenting Mental Wellness: The Promise and Potential of AI in Neuropsychiatric Commercialization
- Discover how AI is transforming diagnostics and treatments in neuropsychiatry.
- Learn about the potential of commercial AI solutions in personalized mental health care.
- Explore how AI integration can revolutionize scalable and effective mental health interventions.
- What are the unique security challenges posed by generative AI in the healthcare sector?
- How can we ensure compliance with healthcare regulations like HIPAA while leveraging generative AI technologies?
- What advanced techniques can be implemented to protect AI systems against cyber threats?
- Case studies demonstrating the successful implementation of secure generative AI applications, enhancing trust and reliability in AI-driven healthcare innovations.
- Uncover how AI helps forecast comorbidity risks in individuals with Type 2 diabetes.
- Gain insights into advanced methods for evaluating the likelihood of complications in diabetes care.
- Examine how AI-driven approaches enhance the early identification and prevention of comorbidities in Type 2 diabetes.
Day 2
- Development of a deep neural network-based model for clinical management of patients with adnexal mass.
- Clinical Utility of the diagnostic test: Aid the physician in surgical consideration decision for adnexal mass risk.
- Understanding the reliability and accuracy of AI enabled diagnostic.
Presentation: AI and IoT for Remote Patient Care: Unlocking New Opportunities
- How are AI-powered wearables enhancing continuous health monitoring for patients?
- What are the benefits of integrating IoT and AI in remote patient care systems?
- What challenges and opportunities exist for using AI in home care and rural healthcare settings?